Status:
COMPLETED
Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine.
Lead Sponsor:
Ain Shams University
Conditions:
Perioperative Diaphragmatic Function
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The aim of our study is to assess differences in the recovery of muscle function, using diaphragm ultrasonography, after reversal of a rocuronium-induced block, using neostigmine versus sugammadex
Detailed Description
Post-operative residual curarization (PORC) remains an essential clinical challenge. The possibility of assessing muscle function and excluding PORC using noninvasive tools in the perioperative period...
Eligibility Criteria
Inclusion
- Patients with American Society of Anesthesiologists' (ASA) physical status I or II or III
- Adult patients aging (18-65) years of both sexes. who undergoing deep neuromuscular block with rocuronium.
- Patients Scheduled for elective FISS surgery
Exclusion
- Patient's refusal of procedure or participation in the study.
- ASA class IV.
- History of hepatic disease (Child Pugh B or C class).
- History of renal disease.
- Allergy or hypersensitivity to sugammadex or neostigmine.
- History of neuromuscular disease.
- Diaphragmatic palsy, pregnancy, nursing.
Key Trial Info
Start Date :
August 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06982092
Start Date
August 26 2024
End Date
January 15 2025
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine, ain shams University
Cairo, Egypt